Propanc Biopharma, Inc. (85)
Browse by Contract Category
Contracts
-
Amended and Restated Employment Agreement, by and between the Company and James Nathanielsz, dated October 26, 2022
(Filed With SEC on November 1, 2022)
-
Securities Purchase Agreement, dated October 6, 2022, by and between the Company and Red Road Holdings Corporation
(Filed With SEC on October 12, 2022)
-
Consultant Agreement by and between the Company and Paul Patrizio, dated October 1, 2021
(Filed With SEC on November 12, 2021)
-
Indemnification Agreement, dated December 23, 2020, by and between Propanc Biopharma, Inc. and Josef Zelinger
(Filed With SEC on December 30, 2020)
-
8% Convertible Promissory Note, dated October 6, 2022, issued by the Company to Red Road Holdings Corporation
(Filed With SEC on October 12, 2022)
-
Securities Purchase Agreement, dated September 21, 2022, by and between the Company and GS Capital Partners, LLC
(Filed With SEC on September 27, 2022)
-
8% Convertible Redeemable Note, dated September 21, 2022, issued by the Company to GS Capital Partners, LLC
(Filed With SEC on September 27, 2022)
-
10% Convertible Redeemable Note, dated August 15, 2022, issued by the Company to ONE44 Capital LLC
(Filed With SEC on August 18, 2022)
-
8% Convertible Redeemable Note, dated August 12, 2022, issued by the Company to GS Capital Partners, LLC
(Filed With SEC on August 18, 2022)
-
Securities Purchase Agreement, dated August 12, 2022, by and between the Company and GS Capital Partners, LLC
(Filed With SEC on August 18, 2022)
-
Securities Purchase Agreement, dated August 15, 2022, issued by the Company to ONE44 Capital LLC
(Filed With SEC on August 18, 2022)
-
Securities Purchase Agreement, dated June 30, 2022, by and between the Company and 1800 Diagonal Lending LLC
(Filed With SEC on July 7, 2022)
-
8% Convertible Promissory Note, dated June 30, 2022, issued by the Company to 1800 Diagonal Lending LLC
(Filed With SEC on July 7, 2022)
-
Securities Purchase Agreement, dated May 12, 2022, by and between the Company and 1800 Diagonal Lending LLC
(Filed With SEC on May 18, 2022)
-
8% Convertible Promissory Note, dated May 12, 2022, issued by the Company to 1800 Diagonal Lending LLC
(Filed With SEC on May 18, 2022)
-
Securities Purchase Agreement, dated April 12, 2022, by and between the Company and Sixth Street Lending LLC
(Filed With SEC on April 18, 2022)
-
8% Convertible Promissory Note, dated April 12, 2022, issued by the Company to Sixth Street Lending LLC
(Filed With SEC on April 18, 2022)
-
Securities Purchase Agreement, dated March 29, 2022, by and between the Company and ONE44 Capital LLC
(Filed With SEC on April 1, 2022)
-
10% Convertible Redeemable Note, dated March 29, 2022, issued by the Company to ONE44 Capital LLC
(Filed With SEC on April 1, 2022)
-
8% Convertible Promissory Note, dated March 7, 2022, issued by the Company to Sixth Street Lending LLC
(Filed With SEC on March 10, 2022)
-
Securities Purchase Agreement, dated March 7, 2022, by and between the Company and Sixth Street Lending LLC
(Filed With SEC on March 10, 2022)
-
8% Convertible Promissory Note, January 3, 2022
(Filed With SEC on January 10, 2022)
-
Securities Purchase Agreement, dated January 3, 2022, by and between the Company and Sixth Street Lending LLC
(Filed With SEC on January 10, 2022)
-
Securities Purchase Agreement, dated December 7, 2021, by and between the Company and ONE44 Lending LLC
(Filed With SEC on December 13, 2021)
-
10% Convertible Promissory Note, dated December 7, 2021, issued by the Company to ONE44 Lending LLC
(Filed With SEC on December 13, 2021)
-
Registration Rights Agreement, by and between the Company and Dutchess Capital Growth Fund LP, dated November 30, 2021
(Filed With SEC on December 7, 2021)
-
Common Stock Purchase Agreement, by and between the Company and Dutchess Capital Growth Fund LP, dated November 30, 2021
(Filed With SEC on December 7, 2021)
-
Securities Purchase Agreement, dated November 26, 2021, by and between the Company and Sixth Street Lending LLC
(Filed With SEC on December 1, 2021)
-
8% Convertible Promissory Note, dated November 26, 2021, issued by the Company to Sixth Street Lending LLC
(Filed With SEC on December 1, 2021)
-
Securities Purchase Agreement, dated October 21, 2021, by and between the Company and Sixth Street Lending LLC
(Filed With SEC on October 27, 2021)
-
8% Convertible Promissory Note, dated October 21, 2021, issued by the Company to Sixth Street Lending LLC
(Filed With SEC on October 27, 2021)
-
8% Convertible Promissory Note, dated September 22, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc
(Filed With SEC on September 28, 2021)
-
Securities Purchase Agreement, dated September 22, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc
(Filed With SEC on September 28, 2021)
-
Securities Purchase Agreement, dated August 19, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc
(Filed With SEC on August 25, 2021)
-
8% Convertible Promissory Note, dated August 19, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc
(Filed With SEC on August 25, 2021)
-
Amended and Restated Director Agreement, by and between the Company and Josef Zelinger, dated August 12, 2021
(Filed With SEC on August 18, 2021)
-
Cancellation Agreement, by and between the Company and Dr. Julian Kenyon, dated August 12, 2021
(Filed With SEC on August 18, 2021)
-
Cancellation Agreement, by and between the Company and James Nathanielsz, dated August 12, 2021
(Filed With SEC on August 18, 2021)
-
Securities Purchase Agreement, dated March 16, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc
(Filed With SEC on March 19, 2021)
-
8% Convertible Promissory Note, dated March 16, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc
(Filed With SEC on March 19, 2021)
-
Securities Purchase Agreement, dated January 5, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc
(Filed With SEC on January 11, 2021)
-
8% Convertible Promissory Note, dated January 5, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc
(Filed With SEC on January 11, 2021)
-
Director Agreement, dated December 23, 2020, by and between Propanc Biopharma, Inc. and Josef Zelinger
(Filed With SEC on December 30, 2020)
-
8% Convertible Redeemable Promissory Note, dated December 10, 2020, issued by the Company to GW Holdings Group, LLC
(Filed With SEC on December 16, 2020)
-
Securities Purchase Agreement, dated December 10, 2020, by and between the Company and GW Holdings Group, LLC
(Filed With SEC on December 16, 2020)
-
Securities Purchase Agreement, dated December 2, 2020, by and between the Company and Geneva Roth Remark Holdings, Inc
(Filed With SEC on December 7, 2020)
-
8% Convertible Promissory Note, dated December 2, 2020, issued by the Company to Geneva Roth Remark Holdings, Inc
(Filed With SEC on December 7, 2020)
-
Form of Prefunded Warrant
(Filed With SEC on April 3, 2020)
-
Form of Series B Warrant
(Filed With SEC on April 3, 2020)
-
Form of Series A Warrant
(Filed With SEC on April 3, 2020)
-
Form of Series C Warrant
(Filed With SEC on April 3, 2020)
-
Form of Securities Purchase Agreement
(Filed With SEC on April 3, 2020)
-
Form of Registration Rights Agreement
(Filed With SEC on April 3, 2020)
-
Form of Second Securities Purchase Agreement
(Filed With SEC on January 17, 2020)
-
Form of First Securities Purchase Agreement
(Filed With SEC on January 17, 2020)
-
Form of Second Convertible Redeemable Promissory Note
(Filed With SEC on January 17, 2020)
-
Form of First Convertible Redeemable Promissory Note
(Filed With SEC on January 17, 2020)
-
Form of Convertible Promissory Note
(Filed With SEC on October 15, 2019)
-
Form of Securities Purchase Agreement
(Filed With SEC on October 15, 2019)
-
Form of Securities Purchase Agreement
(Filed With SEC on October 8, 2019)
-
Form of Convertible Redeemable Promissory Note
(Filed With SEC on October 8, 2019)
-
Common Stock Purchase Warrant for the purchase of up to 225,000 shares of Propanc Biopharma, Inc.s common stock
(Filed With SEC on September 9, 2019)
-
Convertible Promissory Note, issued to Auctus Fund LLC on August 30, 2019 and effective as of September 3, 2019
(Filed With SEC on September 9, 2019)
-
Common Stock Purchase Warrant for the purchase of up to 450,000 shares of Propanc Biopharma, Inc.s common stock
(Filed With SEC on September 9, 2019)
-
Securities Purchase Agreement dated August 30, 2019, by and between Propanc Biopharma, Inc. and Auctus Fund LLC
(Filed With SEC on September 9, 2019)
-
Common Stock Purchase Warrant for the purchase of up to 300,000 shares of Propanc Biopharma, Inc.s common stock
(Filed With SEC on September 9, 2019)
-
Registration Rights Agreement dated August 30, 2019, by and between Propanc Biopharma, Inc. and Auctus Fund LLC
(Filed With SEC on September 9, 2019)
-
Securities Purchase Agreement dated July 30, 2019, by and between Propanc Biopharma, Inc. and Odyssey Capital Funding LLC
(Filed With SEC on August 6, 2019)
-
10% Convertible Note made in favor of Odyssey Capital Funding LLC
(Filed With SEC on August 6, 2019)
-
Securities Purchase Agreement, dated July 3, 2019, by and between the Company and Power Up Lending Group Ltd
(Filed With SEC on July 10, 2019)
-
8% Convertible Promissory Note, dated July 3, 2019, issued by the Company to Power Up Lending Group Ltd
(Filed With SEC on July 10, 2019)
-
Employment Agreement, dated as of June 24, 2019, between Propanc PTY LTD and Carlo Campiciano
(Filed With SEC on July 1, 2019)
-
Form of Pre-Funded Warrant
(Filed With SEC on June 14, 2019)
-
Form of Warrant
(Filed With SEC on June 14, 2019)
-
Form of Securities Purchase Agreement
(Filed With SEC on June 14, 2019)
-
Form of Placement Agent Warrant
(Filed With SEC on June 14, 2019)
-
Form of Placement Agency Agreement
(Filed With SEC on June 14, 2019)
-
Securities Purchase Agreement, dated May 23, 2019, by and between the Company and Redstart Holdings Corp
(Filed With SEC on May 30, 2019)
-
8% Convertible Promissory Note, dated May 23, 2019, issued by the Company to Redstart Holdings Corp
(Filed With SEC on May 30, 2019)
-
Amended and Restated Employment Agreement, dated as of May 14, 2019, between the Company and James Nathanielsz
(Filed With SEC on May 15, 2019)
-
Form of Indemnification Agreement
(Filed With SEC on May 15, 2019)
-
2019 Equity Incentive Plan
(Filed With SEC on May 15, 2019)
-
Amended and Restated Services Agreement, dated as of May 14, 2019, between the Company and Dr. Julian Kenyon
(Filed With SEC on May 15, 2019)
-
Registration Rights Agreement, dated February 25, 2019, by and between the Company and the Investor
(Filed With SEC on February 25, 2019)
-
Equity Purchase Agreement, dated February 25, 2019, by and between the Company and the Investor
(Filed With SEC on February 25, 2019)